Á lódáil...
Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis
BACKGROUND: The elevated calcium and phosphorus levels in patients undergoing hemodialysis may increase the risk of all-cause mortality. Paricalcitol, as a new vitamin D receptor activator (VDRA), seemed to be effective in reducing the calcium and phosphorus levels. OBJECTIVES: The aim of this study...
Na minha lista:
| Foilsithe in: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Dove Medical Press
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445244/ https://ncbi.nlm.nih.gov/pubmed/30992658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S176257 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|